Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is investigating the safety, tolerability, and pharmacokinetics of inhaled CHF6333 in healthy volunteers and in patients with bronchiectasis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• CHF6333 (inhaled) (CHF6333)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Bronchiectasis | Phase 1, Phase 2 | Status: RECRUITING